ArticleThe oncologist2026

Clinical characteristics and drug-drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study.

Simona Pisegna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.